135 related articles for article (PubMed ID: 24749839)
1. Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.
Cornet E; Tomowiak C; Tanguy-Schmidt A; Lepretre S; Dupuis J; Feugier P; Devidas A; Mariette C; Leblond V; Thiéblemont C; Validire-Charpy P; Sutton L; Gyan E; Eisenmann JC; Cony-Makhoul P; Ysebaert L; Troussard X;
Br J Haematol; 2014 Aug; 166(3):390-400. PubMed ID: 24749839
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
Else M; Dearden CE; Matutes E; Garcia-Talavera J; Rohatiner AZ; Johnson SA; O'Connor NT; Haynes A; Osuji N; Forconi F; Lauria F; Catovsky D
Br J Haematol; 2009 Jun; 145(6):733-40. PubMed ID: 19344416
[TBL] [Abstract][Full Text] [Related]
4. Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience.
Au WY; Klasa RJ; Gallagher R; Le N; Gascoyne RD; Connors JM
Blood; 1998 Aug; 92(4):1160-4. PubMed ID: 9694703
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia.
Getta BM; Woo KM; Devlin S; Park JH; Abdel-Wahab O; Saven A; Rai K; Tallman MS
Br J Haematol; 2016 Nov; 175(3):402-409. PubMed ID: 27351754
[TBL] [Abstract][Full Text] [Related]
6. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.
Paillassa J; Cornet E; Noel S; Tomowiak C; Lepretre S; Vaudaux S; Dupuis J; Devidas A; Joly B; Petitdidier-Lionnet C; Haiat S; Mariette C; Thieblemont C; Decaudin D; Validire-Charpy P; Drenou B; Eisenmann JC; Uribe MO; Olivrie A; Touati M; Lambotte O; Hermine O; Karsenti JM; Feugier P; Vaillant W; Gutnecht J; Lippert E; Huysman F; Ghomari K; Boubaya M; Levy V; Riou J; Damaj G; Tanguy-Schmidt A; Hunault-Berger M; Troussard X
Blood Cancer J; 2020 May; 10(5):62. PubMed ID: 32461544
[TBL] [Abstract][Full Text] [Related]
8. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
9. Second cancer risk in hairy cell leukemia: analysis of 350 patients.
Kurzrock R; Strom SS; Estey E; O'Brien S; Keating MJ; Jiang H; Adams T; Talpaz M
J Clin Oncol; 1997 May; 15(5):1803-10. PubMed ID: 9164188
[TBL] [Abstract][Full Text] [Related]
10. Hairy cell leukaemia in the Bloemfontein academic hospitals.
Nel T; Joubert G; van der Ryst E; Bester I
Cent Afr J Med; 1998 Nov; 44(11):286-9. PubMed ID: 10189750
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
[TBL] [Abstract][Full Text] [Related]
13. Cladribine in the treatment of hairy-cell leukaemia.
Goodman GR; Beutler E; Saven A
Best Pract Res Clin Haematol; 2003 Mar; 16(1):101-16. PubMed ID: 12670469
[TBL] [Abstract][Full Text] [Related]
14. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hairy cell leukemia in Iceland.
Kristinsson SY; Vidarsson B; Agnarsson BA; Haraldsdottir V; Olafsson O; Johannesson GM; Eyjolfsson GI; Bjornsdottir J; Onundarson PT; Reykdal S
Hematol J; 2002; 3(3):145-7. PubMed ID: 12111650
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and second neoplasms in hairy cell leukemia: A retrospective cohort.
da Silva WF; Neto AC; da Rosa LI; de Siqueira IA; Amarante GD; Velloso EDRP; Rego EM; Rocha V; Buccheri V
Leuk Res; 2019 Aug; 83():106165. PubMed ID: 31200147
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
18. [Hairy cell leukemia: prognosis and treatment].
Quaresima M; Iacobelli S; Tempera S; Frattarelli N; Bizzoni L; Anaclerico B; Matturro A; Cucchi F; Tafuri A; Pulsoni A
Clin Ter; 2006; 157(2):105-9. PubMed ID: 16817498
[TBL] [Abstract][Full Text] [Related]
19. Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.
Federico M; Zinzani PL; Frassoldati A; Vinceti M; Modè A; Annino L; Chisesi T; Pagnucco G; Invernizzi R; Spriano M; Resegotti L; Bendandi M; Damasio EE;
J Clin Oncol; 2002 Feb; 20(3):638-46. PubMed ID: 11821443
[TBL] [Abstract][Full Text] [Related]
20. Concomitant hairy cell and acute myeloid leukemia.
Rimner T; Went P; Tichelli A; Gratwohl A
Eur J Haematol; 2006 Jan; 76(1):86-8. PubMed ID: 16343277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
